About phyton

This author has not yet filled in any details.
So far phyton has created 13 blog entries.

Phyton Biotech to Present at High-Value Chemicals from Plants Network in Scotland

By | 2018-01-30T17:00:04+00:00 January 30th, 2018|

Phyton Biotech to Present at High-Value Chemicals from Plants Network in Scotland Phyton Biotech is pleased to announce that Dr. Gilbert Gorr, Chief Scientific Officer at Phyton Biotech, will be presenting at Plant Cell Cultures: Production of High-Value Chemicals, an upcoming biotech industry workshop for researchers [...]

Phyton Biotech Unifies International Operations Under New Leadership

By | 2018-01-03T23:47:08+00:00 December 21st, 2017|

Phyton Biotech Unifies International Operations Under New Leadership Restructuring, Appointment of New President Supports Company Growth, Diversified Operations VANCOUVER, Canada, December 21, 2017 – DFB Pharmaceuticals, a Fort Worth, Texas-based private investment group with an entrepreneurial drive for developing new products and businesses in healthcare, announced the promotion of [...]

Phyton Biotech Wins Grant to Develop New Approaches to Manufacturing Artemisinin

By | 2017-11-29T15:59:38+00:00 November 29th, 2017|

Phyton Biotech Wins Grant to Develop New Approaches to Manufacturing Artemisinin Bill & Melinda Gates Foundation Invests in R&D Pilot for Anti-Malarial Active Pharmaceutical Ingredients AHRENSBURG, Germany, November 29, 2017 – Phyton Biotech today announced that it has received a $400,000 grant from the Bill & [...]

Phyton Biotech showcased plant cell fermentation at CPhI Worldwide

By | 2017-11-11T01:54:47+00:00 November 11th, 2017|

Phyton Biotech showcased plant cell fermentation at CPhI Worldwide NOVEMBER 9, 2017 This October, Phyton Biotech attended CPhI Worldwide to exhibit its capabilities and the wide range of applications for the company’s proprietary Plant Cell Fermentation Technology (PCF®). CPhI Worldwide is the largest pharmaceutical industry trade [...]

Case Study: Green Chemistry

By | 2017-10-17T15:58:39+00:00 October 17th, 2017|

Case Study: Green Chemistry Phyton Biotech develops and applies sustainable “green technology” manufacturing solutions for phytochemicals through its award-winning and proprietary Plant Cell Fermentation (PCF®) process. The impact of this revolutionary technology is exemplified by Phyton’s environmentally responsible Paclitaxel manufacturing process. Summary of Problem: [...]

Case Study: Green Chemistry

By | 2017-11-12T23:22:06+00:00 October 7th, 2017|

Case Study: Green Chemistry Phyton Biotech develops and applies sustainable “green technology” manufacturing solutions for phytochemicals through its award-winning and proprietary Plant Cell Fermentation (PCF®) process. The impact of this revolutionary technology is exemplified by Phyton’s environmentally responsible Paclitaxel manufacturing process. Summary of Problem: [...]

Upcoming Conferences

By | 2018-01-24T17:35:20+00:00 October 6th, 2017|

Phyton Biotech will be attending the following conference and exhibition events. Drug, Chemical & Associated Technologies Association (DCAT) Week 2018 March 19-22, 2018 New York City, USA

Phyton Biotech Achieves Manufacturing Milestone with Thapsigargin, the Active Agent in Mipsagargin

By | 2017-11-12T23:20:36+00:00 August 22nd, 2016|

Phyton Biotech Achieves Manufacturing Milestone with Thapsigargin, the Active Agent in Mipsagargin AHRENSBURG, Germany--(BUSINESS WIRE)--Phyton Biotech today announced that it has achieved a major milestone in connection with the manufacture of thapsigargin, an inhibitor derived from the Thapsia plant that is the active agent for the investigational [...]

Patent Application for GenSpera Partner Phyton Biotech Is Published by World Intellectual Property Organization (WIPO)

By | 2017-11-12T23:23:40+00:00 July 13th, 2015|

Patent Application for GenSpera Partner Phyton Biotech Is Published by World Intellectual Property Organization (WIPO)Production of Thapsigargins by Thapsia Cell Suspension Culture" Filed by Phyton Biotech SAN ANTONIO, TX--(Marketwired - Jul 13, 2015) - GenSpera, Inc. (OTCQB: GNSZ) today announced that its strategic partner Phyton Biotech, the pioneer [...]

GenSpera Announces Partnership With Global Supplier

By | 2017-10-07T00:16:40+00:00 February 9th, 2015|

GenSpera Announces Partnership With Global SupplierCompany to Partner with Phyton Biotech for Manufacture of the Key Ingredient in Mipsagargin SAN ANTONIO, Feb. 9, 2015 -- GenSpera, Inc. (OTCQB: GNSZ) today announced a strategic partnership with Phyton Biotech for the manufacture of thapsigargin, which is derived from the thapsia [...]